Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Invested Capital (2017 - 2026)

Inspire Medical Systems' Invested Capital history spans 10 years, with the latest figure at $792.3 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 24.63% to $792.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $792.3 million, a 24.63% increase, with the full-year FY2025 number at $781.2 million, up 13.26% from a year prior.
  • Invested Capital hit $792.3 million in Q1 2026 for Inspire Medical Systems, up from $781.2 million in the prior quarter.
  • Over the last five years, Invested Capital for INSP hit a ceiling of $792.3 million in Q1 2026 and a floor of $225.1 million in Q1 2022.
  • Historically, Invested Capital has averaged $572.7 million across 5 years, with a median of $589.0 million in 2024.
  • Biggest five-year swings in Invested Capital: skyrocketed 133.21% in 2023 and later fell 4.32% in 2025.
  • Tracing INSP's Invested Capital over 5 years: stood at $496.0 million in 2022, then rose by 15.42% to $572.5 million in 2023, then rose by 20.47% to $689.7 million in 2024, then rose by 13.26% to $781.2 million in 2025, then rose by 1.43% to $792.3 million in 2026.
  • Business Quant data shows Invested Capital for INSP at $792.3 million in Q1 2026, $781.2 million in Q4 2025, and $666.5 million in Q3 2025.